Study results indicate that, in a value-based healthcare environment, the value of a knee replacement is measured not only by implant survivorship, but also patient reported outcomes and economic benefits of the procedure.
The report assessed current data from DePuy Synthes’ ATTUNE® Knee Evidence Generation Program. This comprised data from company-initiated studies, investigator-initiated studies, independent studies and national joint registries.
According to analysis, the ATTUNE Knee has thus far demonstrated favorable survivorship, improved patient reported outcomes vs. other knee systems and potential economic benefits, such as 39% lower odds of patient discharge to a skilled nursing facility when implanted with ATTUNE vs. a Triathlon® Knee.
Access a variety of ATTUNE clinical data here.
Study results indicate that, in a value-based healthcare environment, the value of a knee replacement is measured not only by implant survivorship, but also patient reported outcomes and economic benefits of the procedure.
The report assessed current data from DePuy Synthes' ATTUNE® Knee Evidence Generation Program. This comprised data from...
Study results indicate that, in a value-based healthcare environment, the value of a knee replacement is measured not only by implant survivorship, but also patient reported outcomes and economic benefits of the procedure.
The report assessed current data from DePuy Synthes’ ATTUNE® Knee Evidence Generation Program. This comprised data from company-initiated studies, investigator-initiated studies, independent studies and national joint registries.
According to analysis, the ATTUNE Knee has thus far demonstrated favorable survivorship, improved patient reported outcomes vs. other knee systems and potential economic benefits, such as 39% lower odds of patient discharge to a skilled nursing facility when implanted with ATTUNE vs. a Triathlon® Knee.
Access a variety of ATTUNE clinical data here.
Source: DePuy Synthes Companies of Johnson & Johnson
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





